Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature
Punga-Maole, M.L.; Hubert, J.; Mangin, P.
Progres en Urologie Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 5(4): 580-585
1995
ISSN/ISBN: 1166-7087 PMID: 7581512 Document Number: 452017
Bladder retraction is a rare complication of contact chemotherapy with mitomycin C in the treatment of superficial bladder cancer. The clinical and histological features and pathophysiology of this lesion are discussed in the light of a recent case.
Document emailed within 1 workday
Related Documents
Biserte, J.; Rigot, J.M.; Mauroy, B.; Mazeman, E. 1989: Intravesical mitomycin C and superficial bladder tumors Progress in Clinical and Biological Research 303: 411-415Bouffioux, C. 1985: Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given? Progress in Clinical and Biological Research 185b: 47-55
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Baselli, E.C.; Greenberg, R.E. 2000: Intravesical therapy for superficial bladder cancer Oncology 14(5): 719
Kinoshita, N.; Tochigi, H.; Yanagawa, M.; Yamakawa, K.; Sakurai, M.; Hioki, T.; Kawamura, J. 1990: Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside Hinyokika Kiyo. Acta Urologica Japonica 36(3): 257-263
Moriyama, M.; Kubota, Y.; Miura, T.; Shuin, T.; Noguchi, S. 1983: The effect of intravesical chemotherapy on superficial urinary bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 29(3): 351-355
Segawa, N.; Inamoto, T.; Nomi, H.; Ibuki, N.; Azuma, H.; Katsuoka, Y. 2009: Effect of prophylactic intravesical instillation of BCG for superficial bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 55(4): 175-180
Van der Meijden, A.P. 1992: New approaches to intravesical chemo-immunotherapy in superficial bladder cancer Progress in Clinical and Biological Research 378: 95-101
Schreinemachers, L.; Van der Meyden, A.; Steerenberg, P.; Feitz, W.; Groothuis, D.; De Jong, W.; Debruyne, F. 1987: BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 713-716
Maffezzini, M.; Simonato, A.; Lodolo, C.; Raber, M.; Carmignani, G. 1995: Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancer Tumori 81(3): 191-193
Tubaro, A.; Stoppacciaro, A.; Velotti, F.; Bossola, P.C.; Cusumano, G.; Vicentini, C.; De Carli, P.; Ruco, L.; Santoni, A.; Cancrini, A. 1995: Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2 European Urology 28(4): 297-303
Soloway, M.S. 1990: Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG Progress in Clinical and Biological Research 350: 71-79
De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Nonomura, N.; Nishimura, K.; Okuyama, A.; Miki, T.; Kishimoto, T.; Kiyohara, H.; Wakatsuki, A.; Fujioka, H.; Kuroda, H.; Nakano, E.; Takeyama, M.; Koide, T.; Yamaguchi, S. 2001: Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time Hinyokika Kiyo. Acta Urologica Japonica 47(5): 315-319
Hashimura, T.; Shirahase, T.; Inoue, T.; Yamasaki, T.; Terada, N.; Ogura, K.; Arai, Y.; Hida, S.; Ueda, T. 2005: A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer Hinyokika Kiyo. Acta Urologica Japonica 51(7): 439-442
Boccon-Gibod, L. 1989: Intravesical treatment of superficial tumors of the bladder Presse Medicale 18(34): 1685-1686
Matsumura, Y. 1989: Intravesical chemotherapy of superficial bladder tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(2): 193-198
Okamura, K.; Kinukawa, T.; Tsumura, Y.; Otani, T.; Itoh, H.; Kobayashi, H.; Matsuura, O.; Kobayashi, M.; Fukatsu, T.; Ohshima, S. 1998: A randomized study of short-versus long-term intravesical epirubicin instillation for superficial bladder cancer. Nagoya University Urological Oncology Group European Urology 33(3): 285-8; discussion 289
Imamoğlu, M.A.; Bakirtaş, H.; Yiğitbaşi, O.; Ersoy, H.; Sertçelik, A.N. 2001: Intravesical epirubicin treatment following TUR in superficial bladder tumours Archivos Espanoles de Urologia 54(10): 1147-1153
Chopin, D.K. 1998: Intravesical instillation in the treatment of superficial tumors of the bladder Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(2): 268-273